Stock Market

LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. ... More Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Getty Images)Peter Dazeley Question: Why would you pay 81 times earnings for AbbVie stock when you can buy LLY for a similar valuation of 76 times earnings? You wouldn’t, especially when you consider three simple facts: Growth: Eli Lilly's growth rate is accelerating at over 30%, dwarfing AbbVie's under 5%. Over the last three...

Shopify (SHOP -0.64%) stock soared 13% in May, according to data provided by S&P Global Market Intelligence. It reported well-received earnings results, and it benefited from an ease in tariff raises -- for now. Best-in-class e-commerce services Shopify is an e-commerce services provider, offering everything from full website development to single components for omnichannel retailers, including physical hardware. It's gone from its niche of small businesses to become a full commerce giant supporting large, well-known brands with many of its solutions. Like any company that's become top of its industry,...

While stock markets, both Nifty and Sensex, continued to reel under losses for the third consecutive session on Tuesday, shares of Servotech Renewable Power Systems defied the trend with a sharp rally, jumping 19% to hit a three-month high of Rs 147 apiece. What’s Driving Investor Optimism in Servotech? The surge in Servotech’s stock appears to be linked to the high-profile visit of Errol Musk—father of Elon Musk, CEO of Tesla and SpaceX—who arrived in India on June 1 for a five-day strategic tour. Musk senior is part of Servotech’s...

Market Watch: Manish Jain, Head-Fund Management, CentrumOn Nifty from a medium-term perspective, by the end of this calendar year, I’m still very optimistic that you will see closer to 27,000-28,000 levels of Nifty, which is assuming that the P/E multiples continue to remain constant at around 21 times or thereabouts. So you will see markets rallying on the back of earnings growth. I’m fairly optimistic that you will see an acceleration of earnings growth standing where you are today, going into the Q1, I will be very surprised if Nifty...

Stock Market Live Updates: Another important day beckons for the Indian equities today as despite being stuck in a range, the Nifty has been giving opportunities to trade on both sides of the spectrum. The first half of Monday's trading session saw the Nifty react adversely to global cues and fall to the lows of the day with declines of over 200 points. It is then that the bulls stepped in a lead a recovery from the lows, as has been the case over the last month. The Nifty has...

By CNBCTV18.COM |  Jun 3, 2025 7:55 AM IST (Updated)Stock Market Live Updates: Another important day beckons for the Indian equities today as despite being stuck in a range, the Nifty has been giving opportunities to trade on both sides of the spectrum. The first half of Monday's trading session saw the Nifty react adversely to global cues and fall to the lows of the day with declines of over 200 points. It is then that the bulls stepped in a lead a recovery from the lows, as has been the...

Stock market today: Indian frontline indices witnessed a highly volatile trading session on Monday, June 02, but managed to close with minor losses, as bulls ramped up buying after a weak opening, helping stocks recover from early declines.Nifty 50 concluded the session with a mild cut of 0.14%, closing at 24,716 points, after recovering 189 points from the day’s low. The Sensex also recouped its early losses to end the session with a minor decline of 77 points, or 0.09%, at 81,373 points.Despite large-cap indices swinging between gains and losses,...

Why Wall Street's Dr. Doom now wants to be Dr. Boom Nouriel Roubini, the economist renowned for his pessimistic takes on markets and the world economy, is feeling more upbeat lately. The US gained 562,000 millionaires last year as the stock market soared The US stock market surge in 2024 added 562,000 new millionaires, with high-net-worth individuals' wealth increasing by 9.1%, according to Capgemini. Alphabet stock could tumble 25% in a 'black swan' scenario that forces it to divest Google Chrome, Barclays says The worst-case outcome of Google's antitrust case...

CHONGQING, CHINA - OCTOBER 31: The Regeneron webpage is displayed on a smartphone in front of the ... More Regeneron Pharmaceuticals, Inc. logo on October 31, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)Getty Images Regeneron Pharmaceuticals (NASDAQ:REGN) shares witnessed a notable 19% decline on Friday, May 30, in the wake of the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD) treatment in conjunction with Sanofi, during a late-stage clinical trial. One of the two trials did not achieve its primary endpoint, which is a significant setback...

Sensex Today | Stock Market Highlights: The Sensex slipped 77 points to settle at 81,374, while the Nifty closed down 34 points at 24,717. Despite the weakness in largecaps, the broader market outperformed yet again, with the Nifty Midcap index gaining 154 points to end at 55,903, a 600-point rebound from intraday lows. The Nifty Bank index rose 356 points to 57,776, inching closer to its record high.Sensex Today | Stock Market Highlights: After a sluggish start, the Indian equity market staged a smart recovery in the second half of Monday’s...